JAMIE CLABORN: Open Payments
NPI 1205916806 · SILOAM SPRINGS, AR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,156 in 63 payments from 10 companies in 2025. Trend: 2023 $846 · 2024 $1,039 · 2025 $1,156
Food & beverage: $1,142Education: $14
| Company | Payments | Amount |
|---|---|---|
| UCB, Inc. | 12 | $201 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 10 | $193 |
| Janssen Biotech, Inc. | 8 | $159 |
| ABBVIE INC. | 9 | $145 |
| Novartis Pharmaceuticals Corporation | 6 | $119 |
| PFIZER INC. | 6 | $107 |
| Lilly USA, LLC | 5 | $93 |
| Regeneron Healthcare Solutions, Inc. | 2 | $52 |
| E.R. Squibb & Sons, L.L.C. | 3 | $45 |
| Amgen Inc. | 2 | $42 |
Products named: Bimzelx, TREMFYA, SKYRIZI, CIBINQO, Winlevi, COSENTYX, TALTZ, Odomzo.
Industry payments across AR — which companies pay providers there.
